Krystal Biotech OverviewKrystal Biotech EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KRYS.
Quarterly EBIT
$53.69M
↑ 48.41% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$178.81M
↑ 49.59% YoY
Trailing 12 months ending Mar 31, 2026
Krystal Biotech OverviewEBIT (Earnings Before Interest and Taxes) analysis for KRYS.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026